LIfT BioSciences
- Biotech or pharma, therapeutic R&D
LIfT BioSciences is moving into clinic after successfully developing the World’s only Neutrophil based Cell Therapy Platform. Our iPSC derived CAR Alpha Neutrophil Therapy uniquely turns cold tumours hot, kills tumours & recruit other immune cells